These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9356978)

  • 21. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity.
    Abbey M; Owen A; Suzakawa M; Roach P; Nestel PJ
    Maturitas; 1999 Dec; 33(3):259-69. PubMed ID: 10656504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary heart disease risk factors and menopause: a study in 1684 French women.
    Trémollières FA; Pouilles JM; Cauneille C; Ribot C
    Atherosclerosis; 1999 Feb; 142(2):415-23. PubMed ID: 10030394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women.
    Hall G; Collins A; Csemiczky G; Landgren BM
    Maturitas; 2002 Mar; 41(3):177-85. PubMed ID: 11886763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects.
    Manji N; Boelaert K; Sheppard MC; Holder RL; Gough SC; Franklyn JA
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):125-8. PubMed ID: 16430708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy and lipoprotein changes during early menopause.
    Egeland GM; Kuller LH; Matthews KA; Kelsey SF; Cauley J; Guzick D
    Obstet Gynecol; 1990 Nov; 76(5 Pt 1):776-82. PubMed ID: 2170887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
    Heikkinen AM; Niskanen L; Ryynänen M; Komulainen MH; Tuppurainen MT; Parviainen M; Saarikoski S
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):402-7. PubMed ID: 9974425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between subclinical thyroid disease and metabolic syndrome.
    Wang CY; Chang TC; Chen MF
    Endocr J; 2012; 59(10):911-7. PubMed ID: 22785370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical activity and cardiovascular risk factors at menopause: the Nord-Trøndelag health study.
    Gudmundsdottir SL; Flanders WD; Augestad LB
    Climacteric; 2013 Aug; 16(4):438-46. PubMed ID: 23347190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight gain and the menopause: a 5-year prospective study.
    Guthrie JR; Dennerstein L; Dudley EC
    Climacteric; 1999 Sep; 2(3):205-11. PubMed ID: 11910598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could Anthropometric and Lipid Parameters Reflect Susceptibility to Breast Cancer? Comparison of Newly Diagnosed Breast Cancer and Apparently Healthy Women.
    Akalanka HMK; Ekanayake S; Samarasinghe K
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2475-2480. PubMed ID: 30255702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study.
    Campos H; Wilson PW; Jiménez D; McNamara JR; Ordovas J; Schaefer EJ
    Metabolism; 1990 Oct; 39(10):1033-8. PubMed ID: 2120547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of TSH change in a community-based cohort.
    Sigurd LB
    Dan Med J; 2016 Jan; 63(1):B5196. PubMed ID: 26726909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women.
    Lewis-Barned NJ; Sutherland WH; Walker RJ; Walker HL; De Jong SA; Edwards EA; Markham VH
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3534-8. PubMed ID: 10522991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopausal status and risk factors for cardiovascular disease.
    Peters HW; Westendorp IC; Hak AE; Grobbee DE; Stehouwer CD; Hofman A; Witteman JC
    J Intern Med; 1999 Dec; 246(6):521-8. PubMed ID: 10620095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between lipids profile and thyroid parameters in euthyroid diabetic subjects: a cross-sectional study.
    Zhang Y; Lu P; Zhang L; Xiao X
    BMC Endocr Disord; 2015 Mar; 15():12. PubMed ID: 25887732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipids, blood pressure and body weight around the age of the menopause.
    Graff-Iversen S; Thelle DS; Hammar N
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):83-8. PubMed ID: 18277191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of thyroid-stimulating hormone with lipid concentrations: an 11-year longitudinal study.
    Langén VL; Niiranen TJ; Puukka P; Sundvall J; Jula AM
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):120-127. PubMed ID: 27374871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.